About conolidine
These results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the idea of concentrating on ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated disorders.Allows to cut back Continual sorene